Strategies to Maintain Cardiac Risk Control After Discharge From Cardiovascular Risk Reduction Clinic

Providence VA Medical Center200 enrolled

Overview

The purpose of this study is to determine whether a combined behavioral and pharmacological intervention provided by a multidisciplinary team will further reduce LDL-C, smoking, BP and Hb-A1C in diabetic patients with A1c between 7% and 9% when compared to usual care.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

200

Conditions

Diabetes Dyslipidemia Hypertension Coronary Atherosclerosis

Interventions

CounselingBEHAVIORAL

Interactive EducationBEHAVIORAL

Group SupportBEHAVIORAL

Pharmacologic case managementPROCEDURE

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Previous enrollment in Cardiovascular Risk Reduction Clinic (CRRC) * Eligible for CRRC discharge: 1. For DM patients: * HbA1c \< 7.0 %, * BP \< 130/85 mm Hg , and * LDL \< 100 mg/dl; 2. For Non-DM patients: * BP \< 140/90 mm Hg, and * LDL \< 100 mg/dl; * Able and willing to sign informed consent. Exclusion Criteria: * Presence of conditions that might limit long-term compliance (eg, dementia, acute psychiatric decompensation within the previous 6 months, unstable psychiatric disorder); * Metastatic disease or terminal illness

Locations (1)

Providence VAMC

Providence, Rhode Island, United States

Outcomes

Primary Outcomes

The number of patients who had non-compliance to ADA target goals in smoking, LDL cholesterol, blood pressure or Hb A1c.

Time frame: 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.